Offer comparisons / eval

Verily (formerly google life sciences) - remote Level: l5 (senior swe) Base: 205, sign on: 50, equity: 210 over 2 years, perf bonus target: 16%, stock refreshers after year 1 Tc: y1-391, y2-341 Pro: healthcare has upsides, well funded startup relatively safe given market conditions), manager seems good to work with, alphabet benefits, fully remote, like overall mission and product Cons: mixed reviews on culture/ leadership. Non-tech industry Amazon (scot) - Seattle Level: sde2 (swe) Base: 187 , sign on: y1-123/y2-93, equity: 100 units over 4 years (amazons vesting schedule) Tc: y1-324, 319, 287, 287 (perf based stock not included) Pro: sde2 with lesser demands than sde3, cash heavy for 2 years, company / team safe given market conditions), lots of room grow / learn Cons: dreaded Amazon work culture, team can be hit/miss. Sde2 Note: have reached out to recruiter to check if they will match offer Outreach - Seattle Level: staff swe Base: 200 , sign on: 20 over 2 years, equity: 8400 units over 4 years (has value only on ipo), perf target: 10% Pro: good reviews on culture, team / manager seem Really good to work with, company / product has a path forward to profit. Startup upsides over long time Cons: startup with stock value only on ipo, market conditions over next few years, Relatively low tc without reliable stock / refreshers Blind tax: Current base: 219 Stock: 🥜 Yoe:9 #swe #amazon #verily #outreach #offereval

New
yskeu68b Jun 2, 2022

What’s the outreach equity worth today? Your YOE?

Compass nlxV46 OP Jun 2, 2022

They claim valuation between 55-70$ each

New
yskeu68b Jun 2, 2022

I see that’s not enough upside for you. Would take Amazon unless outreach comes up a lot

Microsoft MHqp20 Jun 13, 2022

Which one did you pick? I am expecting an offer from Verily and would like to know more

Microsoft zeus321 Jun 17, 2022

Hey! In a similar situation, what did you end up choosing?

Bloomberg gnvvh Aug 10, 2022

Hey. Can I dm you about your interview at amazon? I’m interviewing with Scot soon.